Introduction
Vascular calcification described abnormal calcium deposition in vessel walls and is a characteristic feature of atherosclerosis, diabetes mellitus, and end-stage renal disease. Vascular calcification is linked to plaque instability and contributes to increased cardiovascular mortality and poor cardiovascular outcomes for patients. Aortic calcification is an important marker in atherosclerosis, and chronic inflammatory diseases, such as atherosclerosis, also contribute to the progression of calcification [1, 2] .
Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is a multifunctional protein involved in base-excision DNA repair and transcriptional regulation of gene expression, as well as playing a pleiotropic role in controlling cellular responses to oxidative stress [3, 4] .
In particular, APE1/Ref-1 reduces intracellular production of reactive oxygen species (ROS) [3] [4] [5] , and overexpression of APE1/Ref-1 suppresses tumour necrosis factor-α-induced monocyte adhesion to endothelial cells [6] and inhibits hypoxia-induced endothelial-cell apoptosis [7] . Moreover, APE1/Ref-1 inhibits balloon-injury-induced neointimal formation in rats [8] , suggesting that it exhibits anti-inflammatory functions in the vascular endothelium.
Vascular smooth muscle cells (VSMCs) can undergo a phenotype change during development [9] . The contractile phenotype of VSMCs is regulated by a balance of several transcriptional factors and can change to support repair processes or return to a normal phenotype. This phenotype change is referred to as phenotypic plasticity or VSMC transition; however, inappropriate phenotype changes occurring under certain conditions, such as high inorganic phosphate (Pi) concentrations, induce vascular calcification via modulation of osteogenic transcription factors [10] .
Several transcription factors, including nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1), are activated by redox regulation of APE1/Ref-1 [11] . Redox signalling associated with APE1/Ref-1 is closely related to cell differentiation and senescence [12] . In particular, inhibition of APE1/Ref-1-mediated redox signalling increases the osteoblastic differentiation of dental papilla cells [13] . However, it remains unknown whether APE1/Ref 
Results

Pi Inhibits APE1/Ref-1 Transcription and Protein Expression
A Pi challenge with ascorbic acid can induce vascular smooth muscle calcification [14] . 
APE1/Ref-1 Suppresses Pi-Induced Calcification in VSMCs
To determine the role of APE1/Ref-1 in Pi-induced VSMC calcification, we studied the effect of adenoviral overexpression of APE1/Ref-1 (200 multiplicity of infection (MOI)). Adenovirus-transfected cells were exposed to Pi (5 mM) in the presence of 10% fatal bovine serum (FBS) for 6 days, and APE1/Ref-1 overexpression in VSMCs was confirmed by Western blot analysis ( Figure 2A ). To evaluate Pi-induced VSMC calcification, we performed alizarin red staining and a calcium-deposition assay. Under basal normal phosphate conditions, vascular calcification was not induced according to the absence of alizarin red staining and the level of calcium deposition ( Figure 2B ,C). However, as expected, vascular calcification was induced under high-Pi conditions (5 mM Pi for 6 days). Adenoviral APE1/Ref-1 overexpression (200 MOI) did not induce vascular calcification; however, APE1/Ref-1 overexpression markedly inhibited Pi-induced VSMC calcification assessed by alizarin red staining and calcium-deposition assay ( Figure 2B,C) . Recently, it was reported that vascular calcification was induced by Pi exposure in an organ culture of the aorta [15] . To investigate whether APE1/Ref-1 inhibits Pi-induced VSMC calcification in an organ culture of the aorta, thoracic aortas were removed from rats (n = 4) and cultured in a medium containing Pi (5 mM) for 6 days. Aortic ring segments were incubated with APE1/Ref-1 (1 × 10 9 plaque-forming units (pfu)) in Dulbecco's modified Eagle medium (DMEM) containing 2% FBS for 24 h, and vascular calcification was assessed by alizarin red/von Kossa staining. Under basal phosphate conditions, no calcification was observed in organ-cultured aortas; however, calcification was observed in endothelial and vascular smooth muscle layers of the aorta upon Pi exposure ( Figure 2D ). Interestingly, adenoviral overexpression of APE1/Ref-1 significantly suppressed Pi-induced aortic calcification (alizarin red staining) and phosphate precipitation (von Kossa staining) in the ex vivo system ( Figure 2E,F) . Pi alone by one-way ANOVA; (C) Calcium-deposition assay using the same conditions as described in (B). To evaluate calcium deposition, cells were decalcified by incubation for 24 h with 0.6 N HCl. The calcium content in the supernatant was determined colourimetrically using O-cresolphthalein and normalized to the protein concentration as described in the Materials and Methods. Each bar represents the mean ± SEM (n = 5). * p < 0.05 vs. control; # p < 0.05 vs. Pi alone by one-way ANOVA. 
APE1/Ref-1 Redox Mutants Are Unable to Suppress Pi-Induced VSMC Calcification
The redox-regulatory domain of APE1/Ref-1 is characterized by two critical cysteine residues (C65 and C93) that are critical for APE1/Ref-1-specific anti-inflammatory activity in endothelial cells [16, 17] . To determine the role of APE1/Ref-1 redox functions, we investigated the effect of adenoviral overexpression of APE1/Ref-1 redox mutants (C65A/C93A) generated by substitutions of C65 and C93 with alanine. Adenoviral overexpression of APE1/Ref-1 C65A/C93A did not suppress Pi-induced calcification, but the loss of the reducing residues instead accelerated this process, as shown by alizarin red staining ( Figure  4A ) and by calcium-deposition assay ( Figure 4B ). This result indicated that the redox mutant of APE1/Ref- Each bar represents the mean ± standard error of the mean (SEM) (n = 5). * p < 0.05 vs. control; # p < 0.05 vs. Pi alone by one-way ANOVA; (C) Calcium-deposition assay using the same conditions as described in (B). To evaluate calcium deposition, cells were decalcified by incubation for 24 h with 0.6 N HCl. The calcium content in the supernatant was determined colourimetrically using O-cresolphthalein and normalized to the protein concentration as described in the Materials and Methods. Each bar represents the mean ± SEM (n = 5). * p < 0.05 vs. control; # p < 0.05 vs. Pi alone by one-way ANOVA. Pi alone by one-way ANOVA; (C) Calcium-deposition assay using the same conditions as described in (B).
To evaluate calcium deposition, cells were decalcified by incubation for 24 h with 0.6 N HCl. The calcium content in the supernatant was determined colourimetrically using O-cresolphthalein and normalized to the protein concentration as described in the Materials and Methods. Each bar represents the mean ± SEM (n = 5). * p < 0.05 vs. control; # p < 0.05 vs. Pi alone by one-way ANOVA. 
The redox-regulatory domain of APE1/Ref-1 is characterized by two critical cysteine residues (C65 and C93) that are critical for APE1/Ref-1-specific anti-inflammatory activity in endothelial cells [16, 17] . To determine the role of APE1/Ref-1 redox functions, we investigated the effect of adenoviral overexpression of APE1/Ref-1 redox mutants (C65A/C93A) generated by substitutions of C65 and C93 with alanine. Adenoviral overexpression of APE1/Ref-1 C65A/C93A did not suppress Pi-induced calcification, but the loss of the reducing residues instead accelerated this process, as shown by alizarin red staining ( Figure  4A ) and by calcium-deposition assay ( Figure 4B ). This result indicated that the redox mutant of APE1/Ref- 
APE1/Ref-1 Suppresses Pi-Induced ROS Production and Apoptosis
Because oxidative stress is related to the pathogenesis of VSMC calcification, we investigated whether APE1/Ref-1 suppresses Pi-induced ROS production in VSMCs. Adenoviral APE1/Ref-1 at 30 MOI to 300 MOI was transfected into VSMCs, which were then incubated with Pi (5 mM) for 1 day. Pi exposure significantly increased intracellular ROS (assessed with 2′,7′-dichlorofluorescin diacetate (H2DCFDA); Figure 5A ) and mitochondrial ROS (assessed with MitoSOX; Figure 5B ) levels; however, Pi-induced intracellular and mitochondrial ROS production were inhibited by APE1/Ref-1 overexpression in an MOI-dependent manner. To investigate whether APE1/Ref-1 inhibits cell death and the expression of genes promoting apoptosis, cytotoxicity was determined by measuring lactate dehydrogenase (LDH) activity in cell-culture medium, and Western blot analysis was used to determine the expression of Bax and Bcl-2 proteins. As shown in Figure 5C 
APE1/Ref-1 Suppresses Pi-Induced Alkaline Phosphatase (ALP) Activity and Osteoblastic Differentiation
ALP promotes calcification by providing Pi to promote mineralization and is a potential therapeutic target against VSMC calcification [18] . To determine whether APE1/Ref-1 inhibits Pi-induced ALP activity, this activity was determined following overexpression of APE1/Ref-1, which significantly inhibited Pi-induced ALP activity ( Figure 6A ). Oxidative stress induces vascular calcification through modulation of osteogenic transcription factors, such as runt-related transcription factor 2 (Runx2) [10] , and pituitary-specific positive transcription factor 1 (Pit-1) was identified as a major phosphate transporter in VSMCs and required for osteochondrogenic differentiation of smooth muscle cells [19] . Our results showed that Runx2 and Pit-1 expression increased following Pi exposure for 6 days; however, APE1/Ref-1 overexpression markedly inhibited Pi-induced Runx2 and Pit-1 expression, suggesting anti-osteoblastic activity from APE1/Ref-1. 
ALP promotes calcification by providing Pi to promote mineralization and is a potential therapeutic target against VSMC calcification [18] . To determine whether APE1/Ref-1 inhibits Piinduced ALP activity, this activity was determined following overexpression of APE1/Ref-1, which significantly inhibited Pi-induced ALP activity ( Figure 6A ). Oxidative stress induces vascular calcification through modulation of osteogenic transcription factors, such as runt-related transcription factor 2 (Runx2) [10] , and pituitary-specific positive transcription factor 1 (Pit-1) was identified as a major phosphate transporter in VSMCs and required for osteochondrogenic differentiation of smooth muscle cells [19] . Our results showed that Runx2 and Pit-1 expression increased following Pi exposure for 6 days; however, APE1/Ref-1 overexpression markedly inhibited Pi-induced Runx2 and Pit-1 expression, suggesting anti-osteoblastic activity from APE1/Ref-1. 
AP1/Ref-1 Suppresses Pi-Induced Loss of VSMC Phenotype
The contractile phenotype of the smooth muscle is defined as the expression of smooth muscle cell proteins, such as α-smooth muscle actin (α-SMA) and smooth muscle protein 22-α (SM22α), which is a calponin-related protein specifically expressed in adult smooth muscles [20] . We investigated the role of APE1/Ref-1 in the expression of VSMC-differentiation markers, such as α-SMA and SM22α. As shown in Figure 7 , α-SMA and SM22α protein levels were significantly decreased by Pi (5 mM) exposure for 6 days; however, this loss of phenotype was recovered by APE1/Ref-1 overexpression. 
Discussion
In this study, we demonstrated a novel role for APE1/Ref [24, 25] . Additionally, hypoxia decreases APE1/Ref-1 levels, followed by significant apoptosis of human umbilical vein endothelial cells [7] . In the present study, chronic exposure to Pi for 6 days decreased APE1/Ref-1 protein expression and APE1/Ref-1-promoter-dependent activity. Therefore, these findings suggest that Pi-induced decreases in APE1/Ref-1 expression are strongly correlated with endothelial oxidative stress and apoptosis, resulting in vascular calcification in VSMCs.
The basic nuclear functions of APE1/Ref-1 include regulation of transcription-factor activity, as well as DNA-repair functions. As an extranuclear function, APE1/Ref-1 inhibits intracellular ROS by inhibiting NADPH oxidase activation by Rac1 GTPase and vascular cell-adhesion molecule-1 expression in endothelial cells [3, 16] . Additionally, APE1/Ref-1 exerts anti-inflammatory activities by reducing the activity of thiol-disulphide exchanges [26] . Gene silencing of APE1/Ref-1 expression decreases basal DNA-repair functions and redox activity, followed by increases in intracellular ROS production [27] . High levels of phosphate-induced apoptosis are associated with mitochondrial dysfunction, such as mitochondrial ROS production [28] , with mitochondrial ROS promoting NF-κB p65 nuclear translocation, followed by phosphate-induced VSMC calcification [29] . In the present 
The basic nuclear functions of APE1/Ref-1 include regulation of transcription-factor activity, as well as DNA-repair functions. As an extranuclear function, APE1/Ref-1 inhibits intracellular ROS by inhibiting NADPH oxidase activation by Rac1 GTPase and vascular cell-adhesion molecule-1 expression in endothelial cells [3, 16] . Additionally, APE1/Ref-1 exerts anti-inflammatory activities by reducing the activity of thiol-disulphide exchanges [26] . Gene silencing of APE1/Ref-1 expression decreases basal DNA-repair functions and redox activity, followed by increases in intracellular ROS production [27] . High levels of phosphate-induced apoptosis are associated with mitochondrial dysfunction, such as mitochondrial ROS production [28] , with mitochondrial ROS promoting NF-κB p65 nuclear translocation, followed by phosphate-induced VSMC calcification [29] . In the present study, APE1/Ref-1 overexpression significantly inhibited Pi-induced ROS production and apoptosis, as well as vascular calcification of VSMCs in vitro and in rat aortas ex vivo. A recent study reported that vascular aldosterone synthase, which can be transcriptionally repressed by APE1/Ref-1, contributes to stimulation of osteochondrogenic transformation in human aortic vascular smooth muscle cells [30] . VSMCs show remarkable phenotype plasticity in response to environmental changes [31] . Phosphate induces calcification in VSMCs and causes phenotypic changes in VSMCs from a contractile to osteochondrogenic phenotype [32] . High levels of phosphates also induce VSMC apoptosis, which is a key regulator of VSMC calcification [33] . In human aortic smooth muscle cells, statins inhibit vascular calcification via the inhibition of apoptosis [34, 35] . Furthermore, high levels of phosphate exposure induce changes in smooth muscle phenotype and result in vascular calcification of VSMCs.
Osteogenic differentiation of VSMCs is characterized by the expression of ALP and Runx2, and oxidative stress induces vascular calcification through modulation of osteogenic transcription factors, such as Runx2. 
Materials and Methods
Chemicals and Reagents
Sodium phosphate (NaH 2 PO4 and Na 2 HPO4), ascorbic acid, alizarin red S, cetylpyridinium chloride, silver nitrate, ethylenediaminetetraacetic acid, ethylene glycol-bis(β-aminoethyl ether)-N,N,N ,N -tetraacetic acid, NP-40, and sodium deoxycholate were purchased from Sigma-Aldrich (St. Louis, MO, USA). Penicillin-streptomycin antibiotic mixture and FBS were purchased from Life Technologies (Grand Island, NY, USA). DMEM and Hanks' balanced salt solution (HBSS) were purchased from Welgene (Daegu, Korea). Phosphatase-and protease-inhibitor cocktails were purchased from Roche Diagnostics (Manheim, Germany). Antibodies specific for Bax, Bcl-2, and α-SMA were purchased from Cell Signaling Technology (Beverly, MA, USA). Antibodies against Runx2 and Pit-1 were obtained from Proteintech Group (Chicago, IL, USA). Anti-β-actin and anti-SM22α were obtained from Sigma-Aldrich and Abcam (Cambridge, MA, USA), respectively. A polyclonal APE1/Ref-1 antibody generated by immunizing rabbits with recombinant human APE1/Ref-1 was prepared in our laboratory [26] .
Primary VSMC Isolation and Cell Culture
VSMCs were obtained from the thoracic aortas of 8-week-old male Sprague-Dawley rats using a tissue explant and enzymatic digestion method [37] . Briefly, rats were euthanized with ketamine (80 mg/kg; intraperitoneal (i.p.)) and xylazine (12 mg/kg; i.p.), the aorta was dissected, and the adventitia was carefully removed with forceps. The aorta was then cut open longitudinally, and the endothelium was gently scraped off with a scalpel. The aorta was cut into squares of~1 mm 2 , which were incubated with 0.25% trypsin at 37 • C for 10 min to remove any remaining adventitia and endothelium. Aorta fragments were placed lumen side down in a tissue-culture flask and cultured in DMEM supplemented with 20% FBS at 37 • C. VSMCs that migrated from the explants were collected and maintained in DMEM containing 10% (v/v) FBS and 1% (v/v) penicillin-streptomycin at 37 • C in a humidified atmosphere containing 5% CO 2 . Cells used in experiments were from passages six to eight. The purity of VSMCs was confirmed by immunocytochemical staining based on positive staining with anti-α-SMA. Animal experiments were approved by the Animal Ethic Committee of Chungnam National University (CNU-00221) and conformed to NIH guidelines for the care and use of laboratory animals.
Induction of VSMC Calcification In Vitro
VSMC calcification was induced according to methods reported previously [14] . Briefly, when confluent cells were incubated in a calcification medium consisting of DMEM supplemented with 10% FBS, 5 mM Pi (a mixture of NaH 2 PO 4 and Na 2 HPO 4 (pH 7.4)), and 50 µg/mL ascorbic acid. The medium was replaced with fresh medium every 2 to 3 days for 6 days.
Adenoviral Transfections
Adenoviruses encoding full-length APE1/Ref-1 (AdAPE1/Ref-1) and a double redox point mutant (C65A/C93A) were used as described previously [16, 38] . Cells were infected at the indicated MOI for 24 h. The total adenoviral transfection was balanced using the same MOI of Adβgal as a control adenovirus.
APE1/Ref-1 siRNA
Rat siRNA and scrambled siRNA were purchased from Bioneer Co. (Daejeon, Korea). VSMCs were transfected with 20 nM chemically synthesized siRNA targeting rat APE1/Ref-1 (5 -GUC UGG UAA GAC UGG AGU ACC-3 ) and scrambled siRNA, which was used as a control, using Lipofectamine RNAiMAX according to manufacturer instructions (Invitrogen, San Diego, CA, USA). One day after the transfection, VSMCs were challenged with the calcification medium, which was replaced with fresh medium every 2 days for 4 days, followed by their use for subsequent experiments.
Evaluation of VSMC Calcification
Alizarin red S staining was used to assess the calcium deposition in VSMCs. Cells were fixed with 70% ethanol at 4 • C for 1 h, followed by staining with 2% alizarin red S (pH 4.2, adjusted with 1.0% NH 4 OH) for 10 min at room temperature. After staining, images were acquired using a Leica DM4000B microscope and DFC420 camera (Leica Microsystems SAS, Wetzlar, Germany). Stained cells were destained with 10% (w/v) cetylpyridinium chloride in 10 mM sodium phosphate (pH 7.0) for 15 min at room temperature. Absorbance of the released alizarin red was measured at 560 nm using an ELISA reader (Bio-Rad, Munich, Germany) and normalized to the protein concentration. To evaluate the calcium deposition, cells were decalcified by incubation for 24 h with 0.6 N HCl. The calcium content in the supernatant was determined colourimetrically using the O-cresolphthalein method and a calcium assay kit (Biovision, Mountain View, CA, USA). After decalcification, cells were washed three times with phosphate-buffered saline (PBS) and solubilized in a solution containing 0.1 N NaOH and 0.1% sodium dodecyl sulphate (SDS). The protein concentration was measured by the Bradford assay (Bio-Rad, Munich, Germany), and calcium content was normalized to the protein concentration. In some ex vivo experiments, von Kossa staining was used to assess the accumulation of Pi, which normally co-precipitates with calcium ions [39] . Aortic sections were treated with a 3% silver nitrate solution, and stained aortas were photographed under light microscopy. ALP activity was determined using the QuantiChrom alkaline phosphatase assay kit (Bioassay Systems, Hayward, CA, USA) according to manufacturer instructions. At the end of incubation, cells were washed with PBS and solubilized with 1% Triton X-100 in 0.9% NaCl. ALP activity was normalized to protein concentrations determined by the Bradford assay (Bio-Rad, Munich, Germany).
Western Blot Analysis
Protein lysates were obtained from cultured VSMCs using RIPA buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM ethylenediaminetetraacetic acid, 1 mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N ,N -tetraacetic acid, 1% NP-40, 1% sodium deoxycholate, and phosphatase-and protease-inhibitor cocktails as described previously [40] . Cell lysates (30 µg total protein) were separated on 12% SDS-polyacrylamide gels and transferred onto a polyvinylidene fluoride membrane. After blocking with 5% non-fat milk for 1 h at room temperature, blots were incubated overnight at 4 • C with primary antibodies, followed by incubation with horseradish peroxidase-conjugated secondary antibodies for 2 h at room temperature. Protein bands were detected using an enhanced chemiluminescence detection kit (Pierce, Rockford, IL, USA).
APE1/Ref-1 Luciferase Reporter Assay
Primary VSMCs were co-transfected with an APE1/Ref-1-promoter-luciferase reporter construct (pGL3; −4000/+65 ,kindly provided by Kishir Bhakat, University of Nebraska Medical Center, Omaha, ME, USA), and a Renilla luciferase control (pRL-TK, Promega, Madison, WI, USA) at a 20:1 ratio using Effectene transfection reagent (Qiagen, Valencia, CA, USA) according to manufacturer instructions. The following day, the medium was changed to calcification medium, and transfected cells were cultured for an additional 4 days. Cells were washed with cold PBS and lysed with passive lysis buffer (Promega, Madison, WI, USA). Luciferase activity was measured using a dual luciferase reporter assay system (Promega, Madison, WI, USA) according to manufacturer instructions. Firefly luciferase activities were normalized to those of the co-transfected Renilla luciferase.
Intracellular and Mitochondrial ROS
Intracellular ROS levels were measured using the fluorescent probe H 2 DCFDA (Invitrogen, San Diego, CA, USA). Cells were washed with HBSS and incubated with 5 µM H 2 DCFDA in HBSS at 37 • C for 30 min. The fluorescence intensity was measured at wavelengths of 485 nm for excitation and 530 nm for emission using a fluorescence microplate reader (Thermo Fisher Scientific, Waltham, MA, USA). Mitochondrial ROS levels were determined using the MitoSOX red mitochondrial superoxide indicator (Invitrogen, San Diego, CA, USA). Cells were washed with HBSS and incubated with 5 µM MitoSOX red in HBSS at 37 • C for 10 min, and fluorescence intensity was measured at wavelengths of 530 nm for excitation and 590 nm for emission using a fluorescence microplate reader (Thermo Fisher Scientific, Waltham, MA, USA).
LDH Activity
To investigate whether VSMC calcification was apoptosis related, cytotoxicity was determined by measuring LDH activity in the cell-culture medium. After the indicated treatments, medium was collected, and LDH concentrations in the extracellular medium were examined using an LDH cytotoxicity detection kit (TaKaRa, Shiga, Japan) according to manufacturer instructions. Cell lysates were scraped, sonicated, and centrifuged at 15,000× g at 4 • C for 30 min. Protein concentration was measured using the Bradford assay (Bio-Rad, Munich, Germany), and cytotoxicity was normalized to protein concentration.
Statistical Analysis
Values are expressed as the mean ± standard error of the mean. Statistical evaluation was conducted using a one-way analysis of variance followed by Tukey's post-hoc test. A p < 0.05 was considered statistically significant.
